Bailey RA - Search Results

1

A post-hoc analysis of the comparative efficacy of canagliflozin and glimepiride in the attainment of type 2 diabetes-related quality measures.

Patel CA, Bailey RA, Vijapurkar U, Meininger G, Blonde L. Patel CA, et al. Among authors: bailey ra. BMC Health Serv Res. 2016 Aug 5;16(a):356. doi: 10.1186/s12913-016-1607-z. BMC Health Serv Res. 2016. PMID: 27495291 Free PMC article.

2

Bailey RA, Vijapurkar U, Meininger GE, Rupnow MF, Blonde L. Bailey RA, et al. Am J Manag Care. 2014 Dec;20(13 Suppl):s296-305. Am J Manag Care. 2014. PMID: 25734218 Free article. Clinical Trial.

3

Bailey RA, Vijapurkar U, Meininger G, Rupnow MF, Blonde L. Bailey RA, et al. Clin Ther. 2015 May 1;37(5):1045-54. doi: 10.1016/j.clinthera.2015.02.020. Epub 2015 Mar 18. Clin Ther. 2015. PMID: 25795432

4

Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin.

Bailey RA, Damaraju CV, Martin SC, Meininger GE, Rupnow MF, Blonde L. Bailey RA, et al. Am J Manag Care. 2014 Jan;20(1 Suppl):s16-24. Am J Manag Care. 2014. PMID: 24512193 Free article. Clinical Trial.

5

Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict.

Bailey RA, Pfeifer M, Shillington AC, Harshaw Q, Funnell MM, VanWingen J, Col N. Bailey RA, et al. BMC Health Serv Res. 2016 Jan 14;16:10. doi: 10.1186/s12913-016-1262-4. BMC Health Serv Res. 2016. PMID: 26762150 Free PMC article. Clinical Trial.

6

Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.

Chow W, Miyasato G, Kokkotos FK, Bailey RA, Buysman EK, Henk HJ. Chow W, et al. Among authors: bailey ra. Clin Ther. 2016 Sep;38(9):2071-82. doi: 10.1016/j.clinthera.2016.07.168. Epub 2016 Sep 3. Clin Ther. 2016. PMID: 27596020

7

Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida.

Tanton D, Duh MS, Lafeuille MH, Lefebvre P, Pilon D, Zhdanava M, Emond B, Inman D, Bailey RA. Tanton D, et al. Among authors: bailey ra. Curr Med Res Opin. 2018 Jun;34(6):1099-1115. doi: 10.1080/03007995.2018.1444591. Epub 2018 Mar 5. Curr Med Res Opin. 2018. PMID: 29468896

8

Real world clinical outcomes and patient characteristics for canagliflozin treated patients in a specialty diabetes clinic.

Johnson JF, Parsa R, Bailey R. Johnson JF, et al. Curr Med Res Opin. 2017 Jan;33(1):77-84. doi: 10.1080/03007995.2016.1238354. Epub 2016 Oct 5. Curr Med Res Opin. 2017. PMID: 27646315

9

Glycemic Control Outcomes After Canagliflozin Initiation: Observations in a Medicare and Commercial Managed Care Population in Clinical Practice.

Bailey RA, Schwab P, Xu Y, Pasquale M, Renda A. Bailey RA, et al. Clin Ther. 2016 Sep;38(9):2046-2057.e2. doi: 10.1016/j.clinthera.2016.07.009. Epub 2016 Aug 23. Clin Ther. 2016. PMID: 27567160

10

Real-world Clinical Outcomes Among Patients With Type 2 Diabetes Receiving Canagliflozin at a Specialty Diabetes Clinic: Subgroup Analysis by Baseline HbA_1c and Age.

Johnson JF, Parsa R, Bailey RA. Johnson JF, et al. Among authors: bailey ra. Clin Ther. 2017 Jun;39(6):1123-1131. doi: 10.1016/j.clinthera.2017.04.006. Epub 2017 May 9. Clin Ther. 2017. PMID: 28495028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page